Gallagher Benefit Services’s Pfizer PFE Stock Holding History

Gallagher Benefit Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$965K	Buy	+18,818	New	+$902K	0.2%	58

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gallagher Benefit Services's PFE Position: Q4 2022 in Review

Gallagher Benefit Services opened a new position in Pfizer (PFE) in Q4 2022: 18,818 shares worth $965K. The stake represents 0.2% of the portfolio and ranks #58 among its holdings.

3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Gallagher Benefit Services held 18,818 shares of Pfizer worth $965K as of Q4 2022.
Pfizer was a new Gallagher Benefit Services position in Q4 2022.
Pfizer made up 0.2% of Gallagher Benefit Services's portfolio in Q4 2022, its #58 holding.
3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Gallagher Benefit Services's 13F filing for Q4 2022, filed 27 Feb 2023.